Mouse ADAM15 Ectodomain Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF945
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse ADAM15
Arg18-Ser694
Accession # O88839
Arg18-Ser694
Accession # O88839
Specificity
Detects mouse ADAM15 Ectodomain in Western blots. In Western blots, approximately 10% cross-reactivity with recombinant human (rh) ADAM15 is observed and less than 1% cross‑reactivity with recombinant mouse ADAM9 and rhADAM8 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Mouse ADAM15 Ectodomain Biotinylated Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Mouse ADAM15
Sample: Recombinant Mouse ADAM15
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ADAM15
ADAM15, also known as MDC15 or metargidin, is a widely expressed metalloproteinase. It is a type I membrane protein that may be involved in cell adhesion and shedding of cell surface proteins.
Long Name
A Disintegrin and Metalloprotease-like Domain 15
Alternate Names
MDC15, Metargidin
Gene Symbol
ADAM15
UniProt
Additional ADAM15 Products
Product Documents for Mouse ADAM15 Ectodomain Biotinylated Antibody
Product Specific Notices for Mouse ADAM15 Ectodomain Biotinylated Antibody
For research use only
Loading...
Loading...
Loading...
Loading...